NEW YORK (GenomeWeb News) – Memorial Sloan-Kettering Cancer Center has joined Sigma-Aldrich’s RNAi Partnership Program, the St. Louis, Mo.-based firm said today.
 
Sigma-Aldrich said that members of the program gain access to products in its functional genomics portfolio including shRNA libraries developed by the RNAi Consortium that target more than 15,000 human genes and 15,000 mouse genes. Sigma-Aldrich is a member of the RNAi Consortium.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.